Article Data

  • Views 1447
  • Dowloads 101

Reviews

Open Access

Primary vaginal melanoma: a case report and literature review

  • M. Schmidt1,*,
  • A. Honig1
  • M. Schwab1
  • P. Adam2
  • J. Dietl1

1Department of Obstetrics and Gynecology, Germany

2Department of Pathology, University of Wuerzburg, Wuerzburg, Germany

DOI: 10.12892/ejgo200803285 Vol.29,Issue 3,May 2008 pp.285-288

Published: 10 May 2008

*Corresponding Author(s): M. Schmidt E-mail: melanie_weigand@hotmail.de

Abstract

Background: Malignant melanoma of the vagina is a rare malignancy associated with high risk of recurrence, distant metastasis and short survival time. Due to the rarity of the disease, no prospective studies or validated treatment recommendations exist. Case: We describe the case of a 54-year-old patient with a locally advanced melanoma located on the anterior vaginal wall. At the time of diagnosis there was no evidence of nodal or distant metastasis. Conclusion: In view of retrospective data in the literature, we treated the patient with colpectomy in terms of a wide local excision only. A more radical approach, adjuvant radio- or chemotherapy did not seem to be justifiable since there are no data demonstrating prolonged survival.

Keywords

Vaginal melanoma; Colpectomy

Cite and Share

M. Schmidt,A. Honig,M. Schwab,P. Adam,J. Dietl. Primary vaginal melanoma: a case report and literature review. European Journal of Gynaecological Oncology. 2008. 29(3);285-288.

References

[1] Weinstock M.A.: “Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival”. Am. J. Obstet. Gynecol., 1994, 171, 1225.

[2] Chang A.E., Karnell L.H., Menck H.R.: “The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society”. Cancer, 1998, 83, 1664.

[3] Petru E., Nagele F., Czerwenka K., Graf A.H., Lax S., Bauer M. et al.: “Primary malignant melanoma of the vagina: long-term remission following radiation therapy”. Gynecol. Oncol., 1998, 70, 23.

[4] Ragnarsson-Olding B., Johansson H., Rutqvist L.E., Ringborg U.: “Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984”. Cancer, 1993, 71, 1893.

[5] Miner T.J., Delgado R., Zeisler J., Busam K., Alektiar K., Barakat R. et al.: “Primary vaginal melanoma: a critical analysis of therapy”. Ann. Surg. Oncol., 2004, 11, 34.

[6] Laufe L.E., Bernstein E.D.: “Primary malignant melanoma of the vagina”. Obstet. Gynecol., 1971, 37, 148.

[7] Carlson J.A., Ross J.S., Slominski A., Linette G., Mysliborski J., Hill J. et al.: “Molecular diagnostics in melanoma”. J. Am. Acad. Dermatol., 2005, 52, 743.

[8] Irvin W.P. Jr., Bliss S.A., Rice L.W., Taylor P.T. Jr., Andersen W.A.: “Malignant melanoma of the vagina and locoregional control: radical surgery revisited”. Gynecol. Oncol., 1998, 71, 476.

[9] Konstadoulakis M.M., Ricaniadis N., Driscoll D.L., Karakousis C.P.: “Malignant melanoma of the female genital system”. Eur. J. Surg. Oncol., 1994, 20, 141.

[10] Ariel I.M.: “Five-year cure of a primary malignant melanoma of the vagina by local radioactive isotope therapy”. Am. J. Obstet. Gynecol., 1961, 82, 405.

[11] Chung A.F., Casey M.J., Flannery J.T., Woodruff J.M., Lewis J.L. Jr.: “Malignant melanoma of the vagina-report of 19 cases”. Obstet. Gynecol., 1980, 55, 720.

[12] Reeves M.E., Coit D.G.: “Melanoma. A multidisciplinary approach for the general surgeon”. Surg. Clin. North Am., 2000, 80, 581.

[13] Reid G.C., Schmidt R.W., Roberts J.A., Hopkins M.P., Barrett R.J., Morley G.W.: “Primary melanoma of the vagina: a clinicopathologic analysis”. Obstet. Gynecol., 1989, 74, 190.

[14] Van Nostrand K.M., Lucci J.A. 3rd, Schell M., Berman M.L., Manetta A., DiSaia P.J.: “Primary vaginal melanoma: improved survival with radical pelvic surgery”. Gynecol. Oncol., 1994, 55, 234.

[15] Gupta D., Malpica A., Deavers M.T., Silva E.G.: “Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases”. Am. J. Surg. Pathol., 2002, 26, 1450.

[16] Cobellis L., Calabrese E., Stefanon B., Raspagliesi F.: “Malignant melanoma of the vagina. A report of 15 cases”. Eur. J. Gynaecol. Oncol., 2000, 21, 295.

[17] Abramova L., Parekh J., Irvin W.P. Jr., Rice L.W., Taylor P.T. Jr., Anderson W.A. et al.: “Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review”. Ann. Surg. Oncol., 2002, 9, 840.

[18] Kim W., Menda Y., Willis J., Bartel T.B., Graham M.M.: “Use of lymphoscintigraphy with SPECT/CT for sentinel node localization in a case of vaginal melanoma”. Clin. Nucl. Med., 2006, 31, 201.

[19] Dhar K.K., Das N., Brinkman D.A., Beynon J.L., Woolas R.P.: “Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature”. Int. J. Gynecol. Cancer, 2007, 17, 720.

[21] Buchanan D.J., Schlaerth J., Kurosaki T.: “Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature”. Am. J. Obstet. Gynecol., 1998, 178, 1177.

[22] Ohno T., Kato S., Sasaki E., Mizutani K., Tsujii H.: “Carbon ion radiotherapy for vaginal malignant melanoma: a case report”. Int. J. Gynecol. Cancer, 2007, Epub ahead of print.

[23] Neven P., Shepherd J.H., Masotina A., Fisher C., Lowe D.G.: “Malignant melanoma of the vulva and vagina: a report of 23 cases presenting in a 10-year period”. Int. J. Gynecol. Cancer, 1994, 4, 379.

[24] Signorelli M., Lissoni A.A., Garbi A., Perego P., Mangioni C.: “Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review”. Gynecol. Oncol., 2005, 97, 700.

Submission Turnaround Time

Top